Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 9 de 9
Filter
Add more filters











Database
Language
Publication year range
1.
Dermatol Online J ; 29(3)2023 Jun 15.
Article in English | MEDLINE | ID: mdl-37591265

ABSTRACT

Combined internal medicine and dermatology (med-derm) training programs were created to advance complex medical dermatology and inpatient dermatology care. A prior study demonstrated that compared to categorical dermatology residents, med-derm residents had less program satisfaction, yet indicated a stronger desire to pursue careers in academia. No follow-up data on practice patterns after training has been reported. We aimed to characterize differences in residency program satisfaction and practice patterns between physicians trained in categorical dermatology compared to med-derm residency programs. We surveyed physicians who graduated from combined med-derm programs along with their counterparts, from six institutions, that either currently or historically had a combined med-derm training, from 2008-2017. Fifty-five percent of med-derm and forty-one percent of categorical-trained physicians responded. The practice patterns between the two groups were similar. A quarter of med-derm physicians continued to provide general internal medicine services. Categorical trained physicians were significantly more satisfied with their training (P=0.03) and performed more excisions on the head/neck (P=0.02). The combined graduates had significantly greater confidence in multidisciplinary care (P=0.003), prescribed more biologic (P<0.001) and non-biologic immunosuppressive agents (P=0.002), and volunteered more for the underserved patients in their communities (P=0.04). Although few differences in overall practice patterns between categorical and med-derm trained graduates were appreciated, med-derm graduates seem more comfortable with multidisciplinary care and may care for more medically complex patients requiring immunosuppression.


Subject(s)
Dermatology , Internship and Residency , Physicians , Humans , Internal Medicine , Head
4.
Clin Dermatol ; 36(6): 714-718, 2018.
Article in English | MEDLINE | ID: mdl-30446193

ABSTRACT

Delusional infestation is the conviction that one is infested with pathogens-either animate or inanimate-despite medical or microbiologic evidence to the contrary. Infestation with inanimate pathogens, specifically fibers or filaments, has been controversially termed Morgellons disease by the patients themselves, who believe that this is not a psychiatric disease but rather a new organic condition or a skin manifestation of an infection, such as Lyme disease. A large-scale study by the Centers of Disease Control and Prevention on patients presenting with Morgellons clinical manifestations did not find evidence of fibers in the skin nor an association with any infection, including Lyme disease. Once the diagnosis of delusional infestation is made, the cornerstone of treatment is antipsychotics, although this is often quite challenging, as patients are reluctant to take these medications.


Subject(s)
Delusional Parasitosis/epidemiology , Delusional Parasitosis/psychology , Morgellons Disease/epidemiology , Morgellons Disease/psychology , Biomedical Research , Centers for Disease Control and Prevention, U.S. , Delusional Parasitosis/pathology , Humans , Internet , Morgellons Disease/pathology , Terminology as Topic , United States/epidemiology
5.
Dermatitis ; 29(2): 66-76, 2018.
Article in English | MEDLINE | ID: mdl-29494385

ABSTRACT

BACKGROUND: Rubber accelerators play a significant role in glove-related occupational contact dermatitis, especially among health care workers. Currently, there is limited information readily available outlining the accelerators used in specific medical examination and surgical gloves. OBJECTIVE: The aim of this study was to ascertain the accelerators used in medical examination and surgical gloves for major glove manufacturers within the United States. METHODS: An initial Internet-based search was performed to establish relevant manufacturers and product lines, with subsequent inquiry with each corresponding company regarding accelerators used in each medical and surgical glove line. RESULTS: Eleven glove manufacturers were identified and contacted. Responses were obtained from all manufacturers, but because of legal limitations, changes in product lines, or inability to supply necessary data, only 8 companies were able to be included in the final analysis, totaling data for 190 gloves. Carbamates were the most common accelerator, used in 90.5% (172/190) of gloves, whereas thiurams were used in only 11 gloves (5.8%). Eight companies surveyed are now advertising and offering touted accelerator-free gloves. CONCLUSIONS: Accelerators are used in most examination and surgical gloves; however, manufacturers are now expanding their product offerings to include accelerator-free options.


Subject(s)
Benzothiazoles/adverse effects , Carbamates , Gloves, Surgical , Rubber/chemistry , Thiram , Carbamates/adverse effects , Dermatitis, Allergic Contact/etiology , Dermatitis, Occupational/etiology , Gloves, Surgical/adverse effects , Guanidines/adverse effects , Hand Dermatoses/etiology , Health Care Sector , Humans , Thiram/adverse effects , United States
8.
Wound Repair Regen ; 17(3): 397-404, 2009.
Article in English | MEDLINE | ID: mdl-19660048

ABSTRACT

During wound healing, some circulating monocytes enter the wound, differentiate into fibroblast-like cells called fibrocytes, and appear to then further differentiate into myofibroblasts, cells that play a key role in collagen deposition, cytokine release, and wound contraction. The differentiation of monocytes into fibrocytes is inhibited by the serum protein serum amyloid P (SAP). Depleting SAP at a wound site thus might speed wound healing. SAP binds to some types of agarose in the presence of Ca(2+). We found that human SAP binds to an agarose with a K(D) of 7 x 10(-8) M and a B(max) of 2.1 microg SAP/mg wet weight agarose. Mixing this agarose 1 : 5 w/v with 30 microg/mL human SAP (the average SAP concentration in normal serum) in a buffer containing 2 mM Ca(2+) reduced the free SAP concentration to approximately 0.02 microg/mL, well below the concentration that inhibits fibrocyte differentiation. Compared with a hydrogel dressing and a foam dressing, dressings containing this agarose and Ca(2+) significantly increased the speed of wound healing in partial thickness wounds in pigs. This suggests that agarose/Ca(2+) dressings may be beneficial for wound healing in humans.


Subject(s)
Hydrogel, Polyethylene Glycol Dimethacrylate/administration & dosage , Serum Amyloid P-Component/administration & dosage , Skin/injuries , Wound Healing/drug effects , Wounds and Injuries/drug therapy , Administration, Topical , Animals , Biopsy , Carrier Proteins , Collagen Type I/metabolism , Disease Models, Animal , Female , Follow-Up Studies , Humans , Immunohistochemistry , Keratins/metabolism , Skin/metabolism , Skin/pathology , Swine , Treatment Outcome , Wound Healing/physiology , Wounds and Injuries/metabolism , Wounds and Injuries/pathology
9.
J Immunol ; 179(6): 4035-44, 2007 Sep 15.
Article in English | MEDLINE | ID: mdl-17785842

ABSTRACT

Fibrotic diseases such as scleroderma, severe chronic asthma, pulmonary fibrosis, and cardiac fibrosis kill tens of thousands of people each year in the U.S. alone. Growing evidence suggests that in fibrotic lesions, a subset of blood monocytes enters the tissue and differentiates into fibroblast-like cells called fibrocytes, causing tissue dysfunction. We previously found that a plasma protein called serum amyloid P (SAP) inhibits fibrocyte differentiation in vitro. Bleomycin treatment is a standard model for pulmonary fibrosis, and causes an increase in collagen, fibrocytes, and leukocytes in the lungs, and a decrease in peripheral blood hemoglobin oxygen saturation. We find that injections of rat SAP in rats reduce all of the above bleomycin-induced changes, suggesting that the SAP injections reduced the bleomycin-induced pulmonary fibrosis. We repeated these studies in mice, and find that injections of murine SAP decrease bleomycin-induced pulmonary fibrosis. To confirm the efficacy of SAP treatment, we used a delayed treatment protocol using SAP from day 7 to 13 only, and then measured fibrosis at day 21. Delayed SAP injections also reduce the bleomycin-induced decrease in peripheral blood hemoglobin oxygen saturation, and an increase in lung collagen, leukocyte infiltration, and fibrosis. Our data suggest the possibility that SAP may be useful as a therapy for pulmonary fibrosis in humans.


Subject(s)
Bleomycin/antagonists & inhibitors , Bleomycin/toxicity , Pulmonary Fibrosis/chemically induced , Pulmonary Fibrosis/therapy , Serum Amyloid P-Component/therapeutic use , Animals , Cell Count , Cell Line , Cell Movement/drug effects , Disease Models, Animal , Drug Administration Schedule , Fibroblasts/drug effects , Fibroblasts/pathology , Humans , Injections, Intraperitoneal , Intubation, Intratracheal , Leukocytes/drug effects , Leukocytes/pathology , Male , Mice , Mice, Inbred C57BL , Pulmonary Fibrosis/pathology , Rats , Rats, Sprague-Dawley , Serum Amyloid P-Component/administration & dosage , Time Factors
SELECTION OF CITATIONS
SEARCH DETAIL